Cordyceps Sunshine Biotech Holdings Co., Ltd. Quarterly Accounts Payable, Current in USD from Q4 2020 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Cordyceps Sunshine Biotech Holdings Co., Ltd. quarterly Accounts Payable, Current history and growth rate from Q4 2020 to Q4 2022.
  • Cordyceps Sunshine Biotech Holdings Co., Ltd. Accounts Payable, Current for the quarter ending December 31, 2022 was $751K, a 572% increase year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $751K +$639K +572% Dec 31, 2022 20-F 2023-05-15
Q4 2021 $112K +$112K +90710% Dec 31, 2021 20-F 2023-05-15
Q4 2020 $123 Dec 31, 2020 20-F 2023-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.